Side Effects

Dr. Adria Schmedthorst

The safe simple drug-free weight loss strategy that works

While GLP-1 drugs like Ozempic and Wegovy are having their moment, we’re learning they can lead to intestinal damage and the possibility of “life-long treatment” to keep weight from returning. Why risk it when researchers say another evidence-based strategy is safer and works?

Carolyn Gretton

The statin that raises your risk of diabetes and cataracts

Doctors often prescribe statins to help lower cholesterol. However, they come with a laundry list of worrying side effects, including a higher risk of dementia, kidney damage and muscle pain. Now we’re finding some statins can increase the risk for diabetes and cataracts…

Dr. Adria Schmedthorst

Blood pressure drugs tied to surprising fracture risk

As our age goes up, so can our risk for fractures. And it’s a risk not to be taken lightly: Fractures have been linked to early death for both men and women, especially in those of us over 65. Not long ago we shared the threat long-term use of blood pressure drugs can pose to our kidneys. Now I need to share another…

Joyce Hollman

Think twice about beta-blockers after a heart attack

Beta-blockers are often prescribed to prevent a second heart attack. But they come with risks of their own. And research shows not everyone benefits from them. This new information will help you talk to your doctor before you decide if they’re right for you.

Carolyn Gretton

The surprising truth about medications and driving

If you take certain medications, you may have seen “Do not operate heavy machinery” on the label. For sleeping pills, that may seem like a given. But there are others you may be surprised to learn could get you into trouble if you take them before driving…

Joyce Hollman

Newer cholesterol drugs linked to reduced lung function

Statins have been controversial almost from the get go. After years of use, the list of side effects has grown along with the number of Americans diagnosed with heart disease, despite the drugs. Enter a new class of cholesterol drug, but is it the same old story?